Skip to main content
Article thumbnail
Location of Repository

How should functionally equivalent drugs be reimbursed? A retrospective analysis of reimbursement for Epoetin-[alpha] and Darbepoetin-[alpha] in 2001-2003 and the cost implications for CMS

By Panos Kanavos and Ömer R Saka
Topics: RA Public aspects of medicine
Publisher: Adis International Ltd
Year: 2005
OAI identifier:
Provided by: LSE Research Online
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://diseasemanagement.adiso... (external link)
  • (external link)
  • Suggested articles

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.